Rika Wakao

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Interstitial Lung Disease

Clinical Decision Support

Top Venues

British journal of clinical pharmacology

BMC health services research

This page only lists publications with an associated author ORCID identifier.

Publications

Shinobu Uzu, Jun Sato, Rika Wakao, Takahiro Nonaka
Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan. BMC health services research 22 (1) (2022)
Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki, Rebecca E Chandler
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan. Drug safety 44 (6) (2021)
Eiko Iwasa, Yu Fujiyoshi, Yuki Kubota, Ryota Kimura, Rebecca E Chandler, Henric Taavola, G Niklas Norén, Rika Wakao
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting. Drug safety 43 (11) (2021)
Ai Fukaya-Shiba, Masafumi Shimokawa, Hajime Sasaki, Rika Wakao
Pharmaceuticals and Medical Devices Agency's horizon scanning and the Science Board: Cooperation toward extracellular vesicle-based products. British journal of clinical pharmacology (2021)